Baird Capital closes single-asset CV for life sciences consulting biz Blue Matter
Tuesday, May 5, 2026 · first reported by PE Hub and 2 others
Baird Capital closes continuation vehicle for life sciences consulting firm Blue Matter, which serves pharma/biotech globally with offices across Europe, North America, and Asia.
- Firm
- Baird Capital
- Also named
- Blue Matter
- Fund
- Baird Capital continuation vehicle (Blue Matter)
- Size
- $450M
- Stage
- Final close
- Asset class
- Private equity
- Geography
- North America, Europe, Asia-Pacific
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
3 sourcesMore on Baird Capital
Everything on this firm →More in Private equity
From the same day- THL Partners beats target with $6.35bn close for tenth flagship buyout fundPrivate Equity Wire +3
- TowerBrook secures $2.7bn at first close of latest flagship buyout fundPrivate Equity Wire
- Reverence Capital Partners’ Osaic gets $2bn of new capital through Ares, Lexington-led CV, recapitalisationAltAssets
- Real Deals newsbreak confirmed: Atlas Health Capital closes debut fundEU.COM +2
- Solum Partners raises $260m for Fund IIIAgri Investor
- Francisco Partners in advanced talks to acquire Moneris in potential $2bn dealPrivate Equity Wire